Versant Venture Capital VI, L.P.

Insider Reports History

Entity
Company
Location
One Sansome Street, Suite 1650, San Francisco, CA
Signature
Versant Venture Capital VI, L.P. By: Versant Ventures VI GP, L.P. Its: General Partner By: Versant Ventures VI GP-GP, LLC Its: General Partner By: /s/ Max Eisenberg Its: Chief Operating Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Versant Venture Capital VI, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Monte Rosa Therapeutics, Inc. 10%+ Owner Common Stock 4.08M $38.4M $9.41 Oct 28, 2024 Direct
Black Diamond Therapeutics, Inc. 10%+ Owner Common Stock 3.73M $23.6M $6.32 Aug 28, 2024 Direct
Century Therapeutics, Inc. 10%+ Owner Common Stock 11.5M $17.1M $1.49 Aug 9, 2022 Direct
Monte Rosa Therapeutics, Inc. 10%+ Owner Common Stock 1.57M $14.8M $9.41 Oct 29, 2024 Indirect
LENZ Therapeutics, Inc. 10%+ Owner Common Stock 2.1M $8.57M $4.08 Mar 21, 2024 Direct
Contineum Therapeutics, Inc. 10%+ Owner Class A Common Stock 376K $6.4M $17.05 Apr 9, 2024 Direct
Black Diamond Therapeutics, Inc. 10%+ Owner Common Stock 822K $5.2M $6.32 Aug 28, 2024 Indirect
LENZ Therapeutics, Inc. 10%+ Owner Common Stock 842K $3.44M $4.08 Mar 21, 2024 Indirect
Contineum Therapeutics, Inc. 10%+ Owner Class A Common Stock 148K $2.53M $17.05 Apr 9, 2024 Indirect
Tempest Therapeutics, Inc. 10%+ Owner Common Stock 2.12M $2.33M $1.10 Aug 8, 2024 Indirect
Century Therapeutics, Inc. 10%+ Owner Common Stock 714K $1.06M $1.49 Aug 9, 2022 Indirect
Tempest Therapeutics, Inc. 10%+ Owner Common Stock 210K $231K $1.10 Aug 12, 2024 Direct
Contineum Therapeutics, Inc. 10%+ Owner Series B Preferred Stock 1.74M Apr 9, 2024 Direct
Contineum Therapeutics, Inc. 10%+ Owner Series A-1 Preferred Stock 1.42M Apr 9, 2024 Direct
Contineum Therapeutics, Inc. 10%+ Owner Series C Preferred Stock 710K Apr 9, 2024 Indirect
Contineum Therapeutics, Inc. 10%+ Owner Series B Preferred Stock 435K Apr 9, 2024 Indirect
Contineum Therapeutics, Inc. 10%+ Owner Series A Preferred Stock 9.25K Apr 9, 2024 Indirect
Oyster Point Pharma, Inc. 10%+ Owner Common Stock 0 $11.20 Jan 3, 2023 Direct
Oyster Point Pharma, Inc. 10%+ Owner Common Stock 0 $11.20 Jan 3, 2023 Indirect

Insider Reports Filed by Versant Venture Capital VI, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GLUE Monte Rosa Therapeutics, Inc. Oct 28, 2024 13 -$1.49M 4 Oct 30, 2024 10%+ Owner
GLUE Monte Rosa Therapeutics, Inc. Sep 20, 2024 1 -$7.4M 4 Sep 24, 2024 10%+ Owner
GLUE Monte Rosa Therapeutics, Inc. Sep 11, 2024 3 -$3.4M 4 Sep 13, 2024 10%+ Owner
BDTX Black Diamond Therapeutics, Inc. Aug 28, 2024 1 -$1.4M 4 Aug 30, 2024 10%+ Owner
TPST Tempest Therapeutics, Inc. Aug 8, 2024 2 -$967K 4 Aug 12, 2024 10%+ Owner
CTNM Contineum Therapeutics, Inc. Apr 9, 2024 21 $0 4 Apr 11, 2024 10%+ Owner
CTNM Contineum Therapeutics, Inc. Apr 4, 2024 0 $0 3 Apr 4, 2024 10%+ Owner
LENZ LENZ Therapeutics, Inc. Mar 21, 2024 1 $0 4 Mar 25, 2024 10%+ Owner
OYST Oyster Point Pharma, Inc. Jan 3, 2023 4 $0 4 Jan 4, 2023 10%+ Owner
IPSC Century Therapeutics, Inc. Aug 9, 2022 2 -$7.17M 4 Aug 11, 2022 10%+ Owner
TPST Tempest Therapeutics, Inc. Apr 29, 2022 0 $0 4 May 3, 2022 10%+ Owner
IPSC Century Therapeutics, Inc. Jan 31, 2022 1 $0 4 Feb 2, 2022 10%+ Owner
OYST Oyster Point Pharma, Inc. Jan 5, 2022 4 $0 4 Jan 7, 2022 10%+ Owner
IPSC Century Therapeutics, Inc. Dec 23, 2021 1 $0 4 Dec 28, 2021 10%+ Owner
OYST Oyster Point Pharma, Inc. Dec 21, 2021 4 $0 4 Dec 23, 2021 10%+ Owner
OYST Oyster Point Pharma, Inc. Oct 18, 2021 4 -$8.16M 4 Oct 20, 2021 10%+ Owner
GRPH Graphite Bio, Inc. Jun 29, 2021 5 $3.06M 4 Jul 1, 2021 10%+ Owner
GLUE Monte Rosa Therapeutics, Inc. Jun 28, 2021 7 $3M 4 Jun 30, 2021 10%+ Owner
TPST Tempest Therapeutics, Inc. Jun 25, 2021 0 $0 3 Jul 6, 2021 10%+ Owner
GRPH Graphite Bio, Inc. Jun 24, 2021 0 $0 3 Jun 24, 2021 10%+ Owner
GLUE Monte Rosa Therapeutics, Inc. Jun 23, 2021 0 $0 3 Jun 23, 2021 10%+ Owner
IPSC Century Therapeutics, Inc. Jun 22, 2021 5 $2M 4 Jun 23, 2021 10%+ Owner
IPSC Century Therapeutics, Inc. Jun 17, 2021 0 $0 3 Jun 17, 2021 10%+ Owner
OYST Oyster Point Pharma, Inc. May 12, 2021 4 $0 4 May 14, 2021 10%+ Owner